Industry Disappointed With England’s Proposed Approach To Innovative Medicines Fund
Executive Summary
Initial optimism about the prospects of speeding up access to rare disease treatments through a new £340m dedicated fund has waned as companies question whether the detailed proposals are workable in practice.